Clinical Trial Update: Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating avelumab plus chemotherapy with or without other anti-cancer immunotherapy agents in advanced malignancies (terminated; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Urothelial Cancer

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Pfizer | Conditions: Non-small Cell Lung Cancer, Urothelial Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-06-23